Blas Couto, Shelley L Forrest, Conor Fearon, Seojin Lee, Samantha Knott, Jun Li, Susan H Fox, Maria Carmela Tartaglia, Anthony E Lang, Gabor G Kovacs
{"title":"Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy","authors":"Blas Couto, Shelley L Forrest, Conor Fearon, Seojin Lee, Samantha Knott, Jun Li, Susan H Fox, Maria Carmela Tartaglia, Anthony E Lang, Gabor G Kovacs","doi":"10.1093/brain/awaf135","DOIUrl":null,"url":null,"abstract":"Progressive supranuclear palsy (PSP) is a neurodegenerative disorder with 4-repeat (R) tau protein deposition. The substantia nigra (SN) and midbrain tegmentum nuclei (MBT) are consistently affected. Lymphocyte infiltrates are scarce in the brain of neurodegenerative diseases, although a few reports have described this feature in brains with the α-synucleinopathy, Parkinson’s disease (PD). To evaluate cytotoxic T-cell response, serial sections spanning 120 microns of the SN were consecutively immunostained for phosphorylated tau (AT8) or α-synuclein, cytotoxic T-cell marker, and microglia marker HLA-DR. Sections were analyzed with stereology software in 9 patients with PSP, 10 with PD, and 6 healthy controls. We semiquantitatively scored CD8-positive cells in further brain regions. CD8 lymphocyte cell counts, and microglial activation were increased in the SN of PSP compared to PD and controls. T-cell/neuron contact was observed in PSP. In multivariate models, CD8 counts were not predicted by disease duration, younger age at death, and by the amount of p-tau pathology. SN and midbrain tegmentum showed more CD8 cells than the cortex. The presence of more prominent nigral cytotoxic T-cell response in PSP than in PD supports the notion that the common p-tau neuropathology in PSP might have potential relationships with autoimmune mechanisms.","PeriodicalId":9063,"journal":{"name":"Brain","volume":"108 1","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awaf135","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder with 4-repeat (R) tau protein deposition. The substantia nigra (SN) and midbrain tegmentum nuclei (MBT) are consistently affected. Lymphocyte infiltrates are scarce in the brain of neurodegenerative diseases, although a few reports have described this feature in brains with the α-synucleinopathy, Parkinson’s disease (PD). To evaluate cytotoxic T-cell response, serial sections spanning 120 microns of the SN were consecutively immunostained for phosphorylated tau (AT8) or α-synuclein, cytotoxic T-cell marker, and microglia marker HLA-DR. Sections were analyzed with stereology software in 9 patients with PSP, 10 with PD, and 6 healthy controls. We semiquantitatively scored CD8-positive cells in further brain regions. CD8 lymphocyte cell counts, and microglial activation were increased in the SN of PSP compared to PD and controls. T-cell/neuron contact was observed in PSP. In multivariate models, CD8 counts were not predicted by disease duration, younger age at death, and by the amount of p-tau pathology. SN and midbrain tegmentum showed more CD8 cells than the cortex. The presence of more prominent nigral cytotoxic T-cell response in PSP than in PD supports the notion that the common p-tau neuropathology in PSP might have potential relationships with autoimmune mechanisms.
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.